Myositis: all 246 studies
Page 3 of 3. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
- Predictor of Clinical Response to Acthar in MyositisCompletedNCT03414086
- Protein Supplementation and Muscle Recovery in FootballCompletedNCT03348267Not applicable
- Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular DystrophiesCompletedNCT03317171Not applicable
- Molecular Profile of the Evolution of Inclusion Body MyositisCompletedNCT03299335Not applicable
- Physical Training in Patients With Idiopathic Inflammatory MyopathiesCompletedNCT03092167Not applicable
- Validation of Rehab Assessments in Myositis PatientsCompletedNCT03059394
- Epidemiological Study of Inflammatory Myopathies in a French RegionCompletedNCT02881450
- Pharmacoepidemiologic General Research Extension: PGRx-sIBM StudyStatus unknownNCT02735447
- Muscle Inflammation and Fat Infiltration in Patients Affected by FSHDStatus unknownNCT02541292
- Kinesio Taping Effects Applied With Different Directions and TensionsCompletedNCT02501915Phase 1
- Natalizumab in Inclusion Body Myositis (IBM)Status unknownNCT02483845Phase 1
- Hyperbaric Oxygen Therapy RegistryStatus unknownNCT02483650
- MYOPROSP - a Prospective Cohort Study in MyositisActive, not recruitingNCT02468895
- Phenomics in Autoimmune and Inflammatory DiseasesCompletedNCT02466217
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- Blood-flow Restricted Exercise in Inclusion Body MyositisCompletedNCT02317094Not applicable
- The Effect of Creatine Supplementation on Muscle Function in Childhood MyositisCompletedNCT02267005Not applicable
- Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related SarcopeniaCompletedNCT02116166
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Natural History in CCFDN and IBM SyndromesCompletedNCT01902940
- Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDCompletedNCT01862926Phase 2/3
- Environmental Risk Factors for Myositis in Military PersonnelCompletedNCT01734369
- Diagnostic Accuracy of MR in MyositisStatus unknownNCT01702870
- Rituximab-induced Pulmonary Function ChangesStatus unknownNCT01632124
- Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body MyositisCompletedNCT01519349Phase 1
- Exercise in Sjogren, Myositis and Takayasu's ArteritisStatus unknownNCT01501019Not applicable
- Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory MyopathiesCompletedNCT01432613Not applicable
- Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisCompletedNCT01423110Phase 2
- Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle InflammationStatus unknownNCT01184625Not applicable
- Investigating Genes in Patients With Polymyositis and DermatomyositisActive, not recruitingNCT01171573
- Anakinra in MyositisCompletedNCT01165008Phase 2/3
- A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory MyopathyCompletedNCT00971828
- Lithium in Inclusion Body Myositis (IBM)CompletedNCT00917956
- Muscle Strength and Inflammatory Response in Patients With Inclusion Body MyositisCompletedNCT00898989
- Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body MyositisCompletedNCT00802815Early Phase 1
- Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia GravisCompletedNCT00774462Phase 2
- Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis PatientsCompletedNCT00519103Not applicable
- Treatment With TNF Blockade, Infliximab, in Patients With MyositisCompletedNCT00443222Phase 2/3
- Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue DiseasesCompletedNCT00341679
- Alemtuzumab to Treat Sporadic Inclusion Body MyositisCompletedNCT00079768Phase 2
- Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile DermatomyositisCompletedNCT00059748
- Study of Families With Twins or Siblings Discordant for Rheumatic DisordersCompletedNCT00055055
- Immune Abnormalities in Sporadic Inclusion Body MyositisCompletedNCT00030212
- Genetic and Family Studies of Inherited Muscle DiseasesCompletedNCT00001331
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2